We came across a bullish thesis on Sana Biotechnology, Inc. (SANA) on wallstreetbets Subreddit Page by Intrepid_Web5454. In ...
As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, ...
We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...
First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP ... Early clinical data from Phase 1 trials and preclinical data published in peer-reviewed journals demonstrate across a variety of ...
Analyst Vikram Purohit from Morgan Stanley maintained a Buy rating on Sana Biotechnology (SANA – Research Report) and keeping the price target ...
SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology ... preclinical and clinical trials, as well as economic, market and social disruptions. For a detailed discussion of the risk ...
Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Sana Biotechnology (SANA – Research Report) yesterday and set a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback